
Researchers from Byers Scientific, Iowa State University, and Texas-based odor experts identified the odor of cannabis.
Researchers from Byers Scientific, Iowa State University, and Texas-based odor experts identified the odor of cannabis.
JMCC Group partners with LYPHE Group Limited to serve medical cannabis patients in the United Kingdom.
Recently, researchers performed a study which discovered that a cannabis plant compound inhibited COVID-19 infection in human lung cells.
Cannabis Science and Technology® is pleased to announce the addition of Richard Sams to its editorial advisory board (EAB).
The 5-part program will dive deep into cultivation, extraction, processing, testing, third-party certifications, and more.
Here we take a closer look at the cannabis industry in Canada and speak to several Canadians involved in the industry.
Gretchen Schmidt, Faculty Program Director Criminal Justice Programs & Cannabis Control at Excelsior College, discusses the graduate certificate program offered at her college.
Chase Towery, the COO of Cultivera, discusses his company, the concerns affecting supply management in the cannabis industry, and much more.
Hemp Processing Partners and United Precision Engineering unveiled a new state-of-the-art hemp refinery facility.
Byers Scientific & Manufacturing and Pacific Environmental Analytics have united together to become Byers Scientific (Byers).
The Battlefront Brothers Foundation received approval from the NIH to move forward with studying how medical cannabis can help veterans with PTSD.
Diane Scott, owner-CEO and Chair of JMCC, recently spoke with us about the medical cannabis landscape, the important research her company is involved in, the roles women play in the industry, and more.
A recent study from University Medical Center Hamburg-Eppendorf Department of Neurology showed promising results in Parkinson's disease patients who used medical cannabis to treat symptoms.
Top cannabis establishments in the industry form the US Cannabis Council (USCC) to help landscape the future of cannabis.
Helix Technologies, Inc. and MOR Analytics have announced the unification of their two companies, becoming Forian Inc..
A new initiative called CannaCareers recently launched and is a collective partnership with NYC-based 501c3 Women of Color in Cannabis, Quality Control Analytics, THC Staffing, and Joint Venture & Co.
In this interview, Brian Smith, PhD, founder, CEO, and CTO at Big Sur Scientific, discusses his work with mid-IR spectroscopy to test for total THC & more.
Avicanna Inc., is growing their epilepsy program through a collaboration with University Health Network.
Cannabis Science and Technology® is pleased to announce the addition of Jack Henion to its editorial advisory board (EAB).
For the 2020-2021 season, the National Basketball Association (NBA) has chosen to freeze random cannabis testing on players, limiting their potential risk of exposure to COVID-19.
Congress passes the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act and the Medical Marijuana Research Act in two historic votes, signifying a growing shift toward cannabis legalization.
United Nations hold historic vote announcing cannabis's Schedule IV removal from the 1961 Single Convention on Narcotics.
Foxx Life Sciences announce new Asia headquarters in India.
Recently the BUCHI Corporation announced a new expansion into Spain, with the establishment of BUCHI Ibérica S.L. in Barcelona.
Tracey Gregory, RN, discusses her experiences with veteran patients with PTSD, her work with Hospice for Heroes, medical cannabis, and more.
Jamie Pascua, a Veterans Affairs caregiver, shares her unique perspective on medical cannabis and her role caring for her disabled veteran spouse.
The Association of Official Agricultural Chemists (AOAC International) announced their new project to develop technical requirements, evaluate, and certify the performance of test kits that calculate total yeast and mold organisms in cannabis flower.
The Dental College of Georgia (DCG) and the Medical College of Georgia, recently performed a study which produced results showing that cannabidiol (CBD), a non-psychoactive cannabinoid found in cannabis, reduces damage in the lungs spurred by cytokine storms caused by coronavirus (COVID-19).
Dr. Junella Chin, the Founder of MedLeaf RX and the Chief Medical Advisor for Yesterday Wellness, discusses with us the beneficial aspects CBD and how the medical field is beginning to incorporate the concept of medical cannabis into patient treatments.
Cannabis Science and Technology®, is thrilled to be hosting “From Post-Traumatic Stress to Post-Traumatic Growth: How Medical Cannabis Is Helping Veterans with PTSD” webcast on Veterans Day, November 11, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET.